2015
DOI: 10.1111/ped.12784
|View full text |Cite
|
Sign up to set email alerts
|

Spontaneous improvement in a pediatric patient with peripheral T‐cell lymphoma

Abstract: Peripheral T-cell lymphoma (PTCL) is rare in children, and it has a poor prognosis compared with other types of lymphoma. We report the case of a 7-year-old boy with spontaneous improvement of PTCL complicated by hemophagocytic syndrome as the initial symptom. He complained of pain and swelling of the right neck and presented with high fever. Pancytopenia, liver dysfunction, elevated ferritin and soluble interleukin 2 receptor were noted on laboratory tests. Peripheral blood plasma and white blood cells were p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…A few larger cohort studies have shown numerous regimens utilized, including anthracycline-based, T-cell NHL-based, and B-cell NHL-based chemotherapy regimens, with or without surgery, radiation, or HSCT (Table 1). 2,[7][8][9][10][11][12] The SEER reported among 103 pediatric patients, 5-year overall survival (OS) of 59% with 10-year OS of 56%, which is better than their adult counterparts, which ranged from 11% to 56% based on their International Prognostic Index. 3,5 The role of HSCT remains controversial in this disease.…”
Section: Discussionmentioning
confidence: 99%
“…A few larger cohort studies have shown numerous regimens utilized, including anthracycline-based, T-cell NHL-based, and B-cell NHL-based chemotherapy regimens, with or without surgery, radiation, or HSCT (Table 1). 2,[7][8][9][10][11][12] The SEER reported among 103 pediatric patients, 5-year overall survival (OS) of 59% with 10-year OS of 56%, which is better than their adult counterparts, which ranged from 11% to 56% based on their International Prognostic Index. 3,5 The role of HSCT remains controversial in this disease.…”
Section: Discussionmentioning
confidence: 99%
“…EBV + PTCL, as a variant of PTCL-NOS, is a rare malignancy which is more frequent in the late adulthood with high clinical stage and aggressive clinical course [ 2 ]. however, for the patients of childhood, it was extremely rare with limited cases have been reported (Additional file 4 : Table S1) [ 4 , 5 , 7 ]. For these cases, lymph node involvement was the significant feature with the common site of cervical region.…”
Section: Discussionmentioning
confidence: 99%